目次

Executive Summary
Market Overview

Market Landscape
Market ecosystem
Value chain analysis

Market Sizing
Market definition
Market segment analysis
Market size 2021
Market outlook: Forecast for 2021 - 2026

Five Forces Analysis
Five Forces Summary
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

Market Segmentation by Product
Market segments
Comparison by Product
Drug - Market size and forecast 2021-2026
Vaccine - Market size and forecast 2021-2026
Diagnostic test - Market size and forecast 2021-2026
Others - Market size and forecast 2021-2026
Market opportunity by Product

Customer landscape
Overview

Geographic Landscape
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2021-2026
Europe - Market size and forecast 2021-2026
APAC - Market size and forecast 2021-2026
South America - Market size and forecast 2021-2026
MEA - Market size and forecast 2021-2026
Key leading countries
Market opportunity by geography

Drivers, Challenges, and Trends
Market drivers
Market challenges
Market trends

Vendor Landscape
Overview
Landscape disruption
Competitive landscape

Vendor Analysis
Vendors covered
Market positioning of vendors
Bayer AG
Boehringer Ingelheim International GmbH
Heska Corp.
Id Vet India Pvt. Ltd.
IDEXX Laboratories Inc.
Merck and Co. Inc.
Pfizer Inc.
Santa Cruz Biotechnology Inc.
Virbac Group
Zoetis Inc.
Zoetis Inc. - Segment focus

Appendix
Scope of the report
Currency conversion rates for US$
Research Methodology
List of abbreviations

Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2021 - 2026 ($ million)
13: Global market: Year-over-year growth 2021 - 2026 (%)
14: Five forces analysis 2021 & 2026
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2021
21: Product - Market share 2021-2026 (%)
22: Comparison by Product
23: Drug - Market size and forecast 2021-2026 ($ million)
24: Drug - Year-over-year growth 2021-2026 (%)
25: Vaccine - Market size and forecast 2021-2026 ($ million)
26: Vaccine - Year-over-year growth 2021-2026 (%)
27: Diagnostic test - Market size and forecast 2021-2026 ($ million)
28: Diagnostic test - Year-over-year growth 2021-2026 (%)
29: Others - Market size and forecast 2021-2026 ($ million)
30: Others - Year-over-year growth 2021-2026 (%)
31: Market opportunity by Product
32: Customer landscape
33: Market share by geography 2021-2026 (%)
34: Geographic comparison
35: North America - Market size and forecast 2021-2026 ($ million)
36: North America - Year-over-year growth 2021-2026 (%)
37: Europe - Market size and forecast 2021-2026 ($ million)
38: Europe - Year-over-year growth 2021-2026 (%)
39: APAC - Market size and forecast 2021-2026 ($ million)
40: APAC - Year-over-year growth 2021-2026 (%)
41: South America - Market size and forecast 2021-2026 ($ million)
42: South America - Year-over-year growth 2021-2026 (%)
43: MEA - Market size and forecast 2021-2026 ($ million)
44: MEA - Year-over-year growth 2021-2026 (%)
45: Key leading countries
46: Market opportunity by geography ($ million)
47: Impact of drivers and challenges
48: Vendor landscape
49: Landscape disruption
50: Industry risks
51: Vendors covered
52: Market positioning of vendors
53: Bayer AG - Overview
54: Bayer AG - Business segments
55: Bayer AG - Key offerings
56: Bayer AG - Key customers
57: Bayer AG - Segment focus
58: Boehringer Ingelheim International GmbH - Overview
59: Boehringer Ingelheim International GmbH - Business segments
60: Boehringer Ingelheim International GmbH - Key offerings
61: Boehringer Ingelheim International GmbH - Key customers
62: Boehringer Ingelheim International GmbH - Segment focus
63: Heska Corp. - Overview
64: Heska Corp. - Business segments
65: Heska Corp. - Key offerings
66: Heska Corp. - Key customers
67: Heska Corp. - Segment focus
68: Id Vet India Pvt. Ltd. - Overview
69: Id Vet India Pvt. Ltd. - Product and service
70: Id Vet India Pvt. Ltd. - Key offerings
71: Id Vet India Pvt. Ltd. - Key customers
72: Id Vet India Pvt. Ltd. - Segment focus
73: IDEXX Laboratories Inc. - Overview
74: IDEXX Laboratories Inc. - Business segments
75: IDEXX Laboratories Inc. - Key offerings
76: IDEXX Laboratories Inc. - Key customers
77: IDEXX Laboratories Inc. - Segment focus
78: Merck and Co. Inc. - Overview
79: Merck and Co. Inc. - Business segments
80: Merck and Co. Inc. - Key offerings
81: Merck and Co. Inc. - Key customers
82: Merck and Co. Inc. - Segment focus
83: Pfizer Inc. - Overview
84: Pfizer Inc. - Business segments
85: Pfizer Inc. - Key offerings
86: Pfizer Inc. - Key customers
87: Pfizer Inc. - Segment focus
88: Santa Cruz Biotechnology Inc. - Overview
89: Santa Cruz Biotechnology Inc. - Product and service
90: Santa Cruz Biotechnology Inc. - Key offerings
91: Santa Cruz Biotechnology Inc. - Key customers
92: Santa Cruz Biotechnology Inc. - Segment focus
93: Virbac Group - Overview
94: Virbac Group - Business segments
95: Virbac Group - Key offerings
96: Virbac Group - Key customers
97: Virbac Group - Segment focus
98: Zoetis Inc. - Overview
99: Zoetis Inc. - Business segments
100: Zoetis Inc. - Key offerings
101: Zoetis Inc. - Key customers
102: Zoetis Inc. - Segment focus
103: Currency conversion rates for US$
104: Research Methodology
105: Validation techniques employed for market sizing
106: Information sources
107: List of abbreviations